Where we at?, page-385

well said.

SW synthesises the issues well

in my view if we have significant delays from the fda / a high n / onerous monitoring costs / more testing on 2x2 etc then we are in very hot water as this all complicates funding of course.

if n comes down / fda (who has already fast tracked us ) is 'just' making very sure as this could be jabbed into hundreds of millions of people but will ultimately approve 2x2 in a timely fashion / there is less onerous monitoring / we get non dilutive cash / we have a chance at breakthrough etc then we are off to the races.

unlike many on HC I don't tell people if they are right or wrong. I try to learn from all informed viewpoints and I do plenty of my own homework. the truth is none of us know how this will play out. it's pretty binary to my mind now and I'm glad many now are more aware of the issues. I have alot of shares, bought at the wrong price and for now I will wait and see what the fda says. as denial said we have 2-3 months to wait now, I don't see much news coming until then.